During the past decade, Long Island Heart Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Long Island Heart Associates" #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Brigham and Women's Hospital" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Long Island Heart Associates" #1 collaborator was "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Long Island Heart Associates" are "Cardiovascular Disease" (5 trials), "Atrial Fibrillation" (3 trials), "Stroke" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Angina" (1 trials). Many other conditions were trialed in "Long Island Heart Associates" in a lesser frequency.

Most popular intervention types in "Long Island Heart Associates" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "Acetylsalicylic acid" (1 trials), "Apixaban" (1 trials) and "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Long Island Heart Associates" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Long Island Heart Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Long Island Heart Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Long Island Heart Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".